160 related articles for article (PubMed ID: 34766298)
1. Protein Mimicry and the Design of Bioactive Cell-Penetrating Peptides: The Genesis of STOPSPERM Bioportides.
Howl J; Silva JV; Fardilha M; Jones S
Methods Mol Biol; 2022; 2383():293-306. PubMed ID: 34766298
[TBL] [Abstract][Full Text] [Related]
2. Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility.
Jones S; Lukanowska M; Suhorutsenko J; Oxenham S; Barratt C; Publicover S; Copolovici DM; Langel Ü; Howl J
Hum Reprod; 2013 Jul; 28(7):1874-89. PubMed ID: 23585561
[TBL] [Abstract][Full Text] [Related]
3. Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics.
Lukanowska M; Howl J; Jones S
Biotechnol J; 2013 Aug; 8(8):918-30. PubMed ID: 23843291
[TBL] [Abstract][Full Text] [Related]
4. Protein Mimicry and the Design of Bioactive Cell-Penetrating Peptides.
Howl J; Jones S
Methods Mol Biol; 2015; 1324():177-90. PubMed ID: 26202270
[TBL] [Abstract][Full Text] [Related]
5. The planarian Schmidtea mediterranea as a model system for the discovery and characterization of cell-penetrating peptides and bioportides.
Jones S; Osman S; Howl J
Chem Biol Drug Des; 2019 Jun; 93(6):1036-1049. PubMed ID: 30790457
[TBL] [Abstract][Full Text] [Related]
6. Disruption of protein phosphatase 1 complexes with the use of bioportides as a novel approach to target sperm motility.
Silva JV; Freitas MJ; Santiago J; Jones S; Guimarães S; Vijayaraghavan S; Publicover S; Colombo G; Howl J; Fardilha M
Fertil Steril; 2021 Feb; 115(2):348-362. PubMed ID: 32977940
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates.
Jones S; Uusna J; Langel Ü; Howl J
Bioconjug Chem; 2016 Jan; 27(1):121-9. PubMed ID: 26623479
[TBL] [Abstract][Full Text] [Related]
8. Bioportide: an emergent concept of bioactive cell-penetrating peptides.
Howl J; Matou-Nasri S; West DC; Farquhar M; Slaninová J; Ostenson CG; Zorko M; Ostlund P; Kumar S; Langel U; McKeating J; Jones S
Cell Mol Life Sci; 2012 Sep; 69(17):2951-66. PubMed ID: 22527714
[TBL] [Abstract][Full Text] [Related]
9. Toxin bioportides: exploring toxin biological activity and multifunctionality.
Kerkis I; de Brandão Prieto da Silva AR; Pompeia C; Tytgat J; de Sá Junior PL
Cell Mol Life Sci; 2017 Feb; 74(4):647-661. PubMed ID: 27554773
[TBL] [Abstract][Full Text] [Related]
10. Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.
Howl J; Jones S
Expert Rev Mol Med; 2015 Jan; 17():e1. PubMed ID: 26258595
[TBL] [Abstract][Full Text] [Related]
11. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide.
Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT
Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794
[TBL] [Abstract][Full Text] [Related]
12. Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
Min S; Kim K; Ku S; Park JY; Seo J; Roh S
Biotechnol Prog; 2020 Sep; 36(5):e3014. PubMed ID: 32374475
[TBL] [Abstract][Full Text] [Related]
13. Cell penetrating peptides: A concise review with emphasis on biomedical applications.
Derakhshankhah H; Jafari S
Biomed Pharmacother; 2018 Dec; 108():1090-1096. PubMed ID: 30372809
[TBL] [Abstract][Full Text] [Related]
14. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant A; Cardon S; Burlina F; Sagan S
Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell Bioengineering with Bioportides: Inhibition of Planarian Head Regeneration with Peptide Mimetics of Eyes Absent Proteins.
Jones S; Matos B; Dennison S; Fardilha M; Howl J
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631231
[TBL] [Abstract][Full Text] [Related]
16. siRNA-cell-penetrating peptides complexes as a combinatorial therapy against chronic myeloid leukemia using BV173 cell line as model.
Freire JM; Rego de Figueiredo I; Valle J; Veiga AS; Andreu D; Enguita FJ; Castanho MA
J Control Release; 2017 Jan; 245():127-136. PubMed ID: 27890856
[TBL] [Abstract][Full Text] [Related]
17. Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cells.
Howl J; Jones S
J Control Release; 2015 Mar; 202():108-17. PubMed ID: 25660072
[TBL] [Abstract][Full Text] [Related]
18. The rational design of cell-penetrating peptides for application in delivery systems.
Kang Z; Ding G; Meng Z; Meng Q
Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
[TBL] [Abstract][Full Text] [Related]
19. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
20. Cell penetrating peptides: the potent multi-cargo intracellular carriers.
Kardani K; Milani A; H Shabani S; Bolhassani A
Expert Opin Drug Deliv; 2019 Nov; 16(11):1227-1258. PubMed ID: 31583914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
